Weight Loss Services Market to Witness Growth Acceleration During 2025

November 04, 2020 - The global weight loss services market size is expected to reach USD 21.1 billion by 2025 expanding at a CAGR of 8.4%. Rising cases of obesity and resultant health consciousness along with increased per capita healthcare expenditure are the key factors fueling the market growth.

Obesity is among the major health concerns that lead to a number of associated diseases or complications, such as diabetes, Cardiovascular Diseases (CVDs), and cancers. For instance, as per WHO, in 2016, more than 1.9 billion adults were overweight, out of which around 650 million people were obese.

In-Depth research report on Weight Loss Services market:    
https://www.radiantinsights.com/research/weight-loss-services-market

Such instances are expected to encourage people to maintain proper health to help lower the risk of such chronic health issues, thereby augmenting market growth. Key companies in the market are focusing on the development of new ways for weight loss, such as Zumba, sports-specific performance training, aquatic exercise classes, and weight loss supplements. For instance, in August 2018, Herbalife International launched Herbalife24 ACHIEVE protein bar, a convenient, energy-providing snack. This product launch may increase the company's popularity among athletes worldwide. Hence, such initiatives are anticipated to drive the market.

Further key findings from the study suggest:

•    Fitness equipment segment is estimated to register the highest CAGR over the forecast period due to advancements by key companies, in terms of technology and equipment

•    Consulting services is projected to expand at the highest CAGR due to their cost-effectiveness as compared to other services

•    APAC is expected to be the fastest-growing regional market in future. Increasing cases of obesity and diabetes due to changing lifestyles are anticipated to drive the region's growth

•    Some of the key companies in the global weight loss services market are Atkins Nutritionals, Inc.; Nutrisystem, Inc.; Herbal Life International, Inc.; Apollo Endosurgery, Inc.; Johnson Health Tech; WW International, Inc.; Kellogg Co; Amer Sports; Cynosure, Inc.; and Diet Health, Inc.

To get free request sample:
https://www.radiantinsights.com/research/weight-loss-services-market/request-sample

Hyaluronic Acid Market to Witness Remarkable Growth

November 02, 2020 - The global hyaluronic acid market size is expected to reach USD 16.6 billion by 2027, expanding at a CAGR of 8.1%. Factors such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers of this market.

The market is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving the compatibility coupled with growing awareness about anti-aging products is fueling the growth. The efficacy and evident results of hyaluronic acid based dermal fillers are attracting this population base.

In-Depth research report on Hyaluronic Acid market:    
https://www.radiantinsights.com/research/hyaluronic-acid-market

The global increase in population also results in an increased demand for antiaging cosmetic and aesthetic treatments. Owing to its distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels, hyaluronic acid products are directly affected by growing demand for minimally invasive antiaging solutions. The minimal adverse effects, lower pain, shorter recovery time, and lesser postsurgical complications make minimally invasive surgeries significantly attractive.

Further key findings from the study suggest:

• The osteoarthritis segment held the largest share in 2019. In 2013, more than 27 million people were suffering from osteoarthritis. Viscosupplements are gaining popularity as a cure in pain management. Use of hyaluronan as a treatment for osteoarthritis has been approved by the U.S. FDA in 1997 and has gained substantial market share

• The rising obesity resulting in osteoarthritis and joint pain has increased the demand for hyaluronic acid injections as treatment. With the prevailing consumer trend, which favors convenience over higher costs, companies such as Genzyme (Sanofi-Aventis) and Zimmer have launched single-injection products. The 2014 FDA approval for single-injection treatment “MONOVISC” is expected to further fuel the growth of the single-injection product segment

• Cosmetic surgeries are booming with approximately 14 million minimally invasive procedures performed every year. In 2013, hyaluronan-based facial fillers received FDA approval, which is used in corrective measures, anti-aging procedure, and filling fine lines. These dermal fillers constitute a large share in these procedures and witnessed 8% growth in the year 2014

• Growing preference for short-treatment regimens, even though high priced, and growing prevalence of target diseases, such as osteoarthritis, are high impact rendering factors that can be attributed for the large share of this region. In 2019, the most lucrative applications of hyaluronic acid in the North American region were in the form of dermal fillers and viscosupplements for management of osteoarthritis

• Hyaluronic acid market in Asia Pacific region is anticipated to emerge as the fastest growing region during the forecast period. The growing geriatric population in China and Japan provides a large customer base for anti-aging products and services. Increasing awareness about applications of hyaluronan and its efficacy fuels the demand. In addition, stabilizing economies leaves the middle-class population with surplus money to spend on these procedures

• The industry is presently dominated by key participants such as F. Hoffmann-La Roche Ltd.; Seikagaku Corporation; Galderma S.A; Sanofi (Genzyme); Anika Therapeutics Inc.; Salix Pharmaceuticals; Zimmer Holdings Inc.; Allergan Inc.; Ferring Pharmaceuticals, Inc.; and Smith & Nephew Plc.

To get free request sample:
https://www.radiantinsights.com/research/hyaluronic-acid-market/request-sample

Tissue Expander Market: Revenue Growth and Applications Insights

October 06, 2020 - The global tissue expanders market is anticipated to reach USD 1.5 billion by 2025. This growth can be attributed to increase in the number of reconstruction surgeries.

Growing concern among people regarding their physical appearance has led to a rapid growth of the tissue expanders market. In the U.S., over 102,200 breast reconstruction procedures were performed in 2014, which showcase a 7% rise from the previous year, as estimated by the American Society of Plastic Surgeons. In addition, cleft lip surgeries that are prevalent among the pediatric population also require tissue expanders. Thus, rise in the number of these surgeries has led to a huge growth of this market.

In-Depth research report on Tissue Expander market:
https://www.radiantinsights.com/research/tissue-expander-market

According to the Agency for Healthcare Research and Quality, the percentage of women undergoing mastectomy procedures has increased by 36% from 2005 to 2013. Thus, growing number of mastectomies is anticipated to drive the demand for tissue expanders. In addition, burns and road accidents result in severe scars or deformities, which most often require surgical treatment. Hence, there is a steep rise in the number of reconstructive surgeries that make use of tissue expanders for such severe scars or deformities, which aids in market growth.

Further key findings from the study suggest:

• In 2016, breast reconstruction held the largest market share owing to large number of breast reconstruction surgeries performed

• Forehead skin and scalp reconstruction is anticipated to witness lucrative growth over the forecast period due to increase in number of cicatricial alopecia cases

• Anatomical-shaped tissue expanders dominated the market in 2016 due to their natural-looking appearance

• Round-shaped expanders are expected to display fastest growth over the forecast period due to lower risk of expander ripples through the skin

• Hospitals held the largest revenue share in 2016 due to large number of reconstruction surgeries being performed in hospitals

• Cosmetology clinics are anticipated to witness significant growth over the forecast period due to the huge demand for specialty clinics for reconstructive procedures

• North America dominated the market in 2016 due to increase in the number of reconstruction surgical procedures being conducted in this region

• Asia Pacific is projected to exhibit fastest CAGR over the forecast period due to increase in road accidents and trauma cases in this region and developing healthcare infrastructure

• Some of the major companies in the market are Mentor Worldwide LLC; Sientra, Inc.; Allergan; GROUPE SEBBIN SAS; Eurosilicone; and KOKEN CO., LTD.

To get free request sample:
https://www.radiantinsights.com/research/tissue-expander-market/request-sample

Global cartilage repair/regeneration market is expected to witness lucrative growth over the forecast period

September 23, 2020 - The global cartilage repair/regeneration market is expected to reach USD 6.7 billion by 2025. The market is expected to witness lucrative growth over the forecast period, owing to increasing prevalence of bone & joint disorders, such as Osteoarthritis (OA), rising geriatric population, and surge in number of accidents & related injuries across the globe.

Increasing number of road accidents worldwide are causing bone and joint injuries, which is anticipated to fuel the demand for cartilage repair products over the forecast period. For instance, as per data published by the World Health Organization (WHO) in November 2016, approximately 1.25 million people die each year in road accidents worldwide, owing to the influence of alcohol & reckless driving, use of mobile phone, and other associated factors such as bad weather conditions & improper road construction.

In-Depth research report on Cartilage Repair/Regeneration market:    
https://www.radiantinsights.com/research/cartilage-repair-regeneration-market

Around 30.0 million children and adolescents participate in youth sports in the U.S each year. This increase in sports activity increases incidents of injuries in athletes, which in turn propels demand for cartilage repair products. According to research data by the American Orthopaedic Society for Sports Medicine, over 3.5 million athletes receive medical treatment due to sports injuries each year.

Further Key Findings From the Study Suggest:

• The cell-based segment held a profitable revenue share in 2016 and is anticipated to grow at a significant rate over the forecast period owing to rising preference for autologous chondrocyte transplantation for surgical treatment of damaged articular cartilage (chondral and osteochondral lesions)

• The hyaline cartilage segment is anticipated to witness the fastest growth during the forecast period due to high susceptibility of damage to hyaline cartilage in case cartilage-related injuries and increase in sport injuries

• Owing to the extensive use of microfracture techniques during cartilage repair surgeries, the intrinsic repair stimulus segment dominated the market in 2016

• Increasing prevalence of OA and rise in accident-related injuries are anticipated to support the growth of knee cartilage repair segment

• North America is expected to dominate the cartilage repair market during the forecast period, owing to the rising prevalence of bone & joint disorders, increase in number of accidents & injuries, and growing geriatric population in the region are expected to spur the cartilage regeneration market growth.

• Some of the key players of cartilage repair market are Zimmer Biomet; Stryker Corporation; DePuy Synthes; Smith & Nephew plc; Vericel Corporation; Osiris Therapeutics Inc.; B. Braun Melsungen AG; Anika Therapeutics, Inc.; Arthrex, Inc.; and Collagen Solutions Plc.

To get free request sample:
https://www.radiantinsights.com/research/cartilage-repair-regeneration-market/request-sample

Global breast imaging market is expected to reach USD 7.3 billion by 2024

September 10, 2020 - The global breast imaging market is expected to reach USD 7.3 billion by 2024. Increasing prevalence of breast cancer and supportive government initiatives to increase awareness are expected to boost demand in the market.

Supportive government initiatives such UK government campaign's "Be clear on cancer," which helped in spreading awareness about the risk factors, preventive measures, and early diagnosis of cancer. This campaign also included free screening programs, which helped in diagnosing around 15,000 cancer patients.

Read full research report:
https://www.radiantinsights.com/research/breast-imaging-market

Technological advancements in the imaging sector are expected to boost growth in the market. Companies such as Gamma Medica, Dilon Technologies, and SonoCine are completely dedicated to developing improved technologies in the field of breast imaging. The innovation of complimentary products such as the breast pad designed by GE Healthcare to provide comfort to a woman undergoing screening is expected to catalyze the market growth further.

Further key findings from the report suggest:

• The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.

• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, promotes the development of personalized medicine, which is anticipated to foster market growth.

• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.

• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.

To get free request sample:
https://www.radiantinsights.com/research/breast-imaging-market/request-sample

Negative pressure wound therapy is one of the commonly accepted therapies employed for the treatment of arterial ulcers

August 31, 2020 - The global negative pressure wound therapy (NPWT) market is anticipated to reach a value of USD 4.0 billion by 2025. Increasing awareness in the developing regions pertaining to advanced wound care is providing a significant opportunity to the key market players to cater to the unmet needs of the target population. The primary driver associated with this market is the cost-effectiveness of single-use negative pressure wound therapy devices.

Major companies are also focusing on education of reimbursement coverage in such regions to further increase the affordability of these devices. However, the current reimbursement policies mostly cover conventional NPWT devices owing to their high cost. Furthermore, the geriatric population is also contributing to a great extent toward increasing the prevalence of chronic diseases. Increasing age is one of the high risk factors leading to the development of chronic diseases such as atherosclerosis, which is one of the prime cardiovascular disorders prevalent in the geriatric population.

Browse full research report:
https://www.radiantinsights.com/research/negative-pressure-wound-therapy-market 

NPWT is one of the commonly accepted therapies employed for the treatment of arterial ulcers, which is one of the major complications of atherosclerosis. Around 50% of the people worldwide are exposed to fire-related traumas, among which, 90% of the cases occur in low to moderate income countries.Thus, the rising incidence of traumatic events is expected to engender a high demand for negative pressure wound therapy products.

Further Key Findings from the Study Suggest:

• Conventional NPWT devices dominated the product segment in 2015 owing to their high cost and availability of favorable reimbursement policies

• Single-use negative pressure wound therapy devices segment is considered to be the fastest growing segment over the forecast period

• Diabetic foot ulcer held the largest revenue share in 2015 owing to its numerous applications,thus yielding a high success rate using NPWT

• Home care setting is anticipated to witness an attractive CAGR over the forecast period owing to the emerging applicability of single-use NPWT devices in the home care setting and cost-effectiveness of the therapy

• North America dominated the overall NPWT market in 2015. This is primarily due to the increased usage of the target therapy in this region, which has led to a reduction in hospital stays and contributed toward enhanced quality of patient lives

• Some key companies in this market are Acelity L.P. Inc., Smith & Nephew, Mölnlycke Health Care, Talley Group Limited, ConvaTec Inc., Devon Medical, Cardinal Health, Inc., DeRoyal Industries, Inc., Medela AG and Paul Hartmann AG.

Download free request sample:
https://www.radiantinsights.com/research/negative-pressure-wound-therapy-market/request-sample

Therapeutic Respiratory Devices Market to Witness Increasing Growth

August 26, 2020 - The global therapeutic respiratory devices market is anticipated to reach USD 18.0 billion by 2025. Growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements are the key factors that are driving the market growth.

The therapeutic respiratory devices market growth is anticipated to increase due to rapid technological advancements in the market.Now-a-days, the respiratory monitoring devices utilize software applications for the collection and analysis of data from ventilators equipped across the health system. The tools in the software application allow improvised patient monitoring by the measurement of parameters such as process and clinical variation in the ventilator therapy.

Browse full research report:
https://www.radiantinsights.com/research/therapeutic-respiratory-devices-market

Furthermore, waveform capnography is a useful technical advancement in monitoring the carbon dioxide levels. The launch of new products such as automated and stand-alone pressure controller for mechanical ventilators boost the growth of therapeutic respiratory devices market. These pressure controllers enable reduction in the risk of tracheal injuries and Ventilator Associated Pneumonia (VAP). For instance, in May 2015, Fischer and Paykel launched its new product AIRVO Nasal High Flow System, which provides comfort and stability for patients. It has soft contoured cheek pads and prongs, uninterrupted power supply transport, and tube technology with two way spiral design. The company also offers humidifier with integrated flow generator, which delivers high flows of air mixture to spontaneously breathing patient. Such factors are bolstering the growth of the market.

Further key findings from the study suggest:

• Positive airway pressure devices accounted for the largest share in 2016 owing to technological innovations resulting in increased portability and shelf life.

• HEPA filter technology accounted for the largest share in 2016, due to the prevalence of respiratory diseases & their transmission coupled with technological advancements in this segment.

• Humidifiers is anticipated to be the fastest growing segment in the forecast period owing to the rising demand for humidifiers in hospitals, schools, home, & healthcare entities, and increased prevalence of airborne infections such as tuberculosis.

• North America therapeutic respiratory devices market is the largest market and is expected to maintain its position over the forecast period owing to the presence of large geriatric population base and rising prevalence of chronic respiratory diseases.

• Major players of the market include, Carefusion Corporation, GE Heathcare, AirSep Corporation, Philips Healthcare, Smiths Medical and Covidien PLC.

To get free request sample:
https://www.radiantinsights.com/research/therapeutic-respiratory-devices-market/request-sample

Global cleanroom technology market size is expanding at a CAGR of 3.8% by 2027

August 06, 2020 - The global cleanroom technology market size is expected to reach USD 5.3 billion by 2027, expanding at a CAGR of 3.8%. Technological advancement in cleanroom equipment, increasing need for cleanroom technology to develop quality products, and initiatives taken by private and public organizations to create awareness are key factors driving market growth.

Read full research report :
https://www.radiantinsights.com/research/cleanroom-technology-market

Manufacturing companies in various industries are dependent on cleanroom technology in order to comply with the stringent regulatory standards. Moreover, there has been an increase in need for standardizing cleanroom standards due to presence of a wide range of classifications used by different countries such as U.S., U.K., and Germany, which is further bolstering the growth.

The standards are more stringent among pharmaceutical and medical devices industries as compared to other industries owing to high chances of adverse consequences on public health in case of noncompliance. These factors are also expected to propel the growth of the cleanroom technology market in various industries. Moreover, various initiatives such as presence of cleanroom company directories and online magazines for specifying trends in cleanroom technology is further fueling the market.

Increase in incidence of healthcare-acquired infections (HAIs) is expected to propel the market in the coming years. According to a report by CDC, there were nearly 722,000 HAIs in U.S. as of 2018. Likewise, according to the data published by the National Institute for Health and Care Excellence, in England, about 300,000 patients a year acquire HAI as a result of care within the National Health Service. Thus, the need for installation of cleanroom in hospitals has increased significantly to overcome the growing incidence of HAIs.

Further key findings from the report suggest:

• Consumables held the largest revenue share owing to the stringent regulatory guidelines and increase in demand for quality products

• Pharmaceutical industry dominated the end-use segment due to several factors such as increasing demand to install the cleanroom technology equipment in production unit and presence of stringent regulations in U.S. regarding approval of imported products from emerging countries

• Asia Pacific region is anticipated to exhibit lucrative growth over the forecast period. The growth can be attributed to the increased production of generics, growing government initiatives, and economic development

• The key players in the cleanroom technology market include M+W Group; Clean Air Products; Abtech; KCWW; DuPont; Clean Room Depot, Inc.; Integrated Clean Room Technologies Pvt Ltd; Terra Universal; and Labconco.

Download free request sample :
https://www.radiantinsights.com/research/cleanroom-technology-market/request-sample

Global medical device validation and verification market size is expected to reach USD 1.1 billion by 2027

April 15, 2020 - The global medical device validation and verification market size is expected to reach USD 1.1 billion by 2027, expanding at a CAGR of 11.1% over the forecast period.

Increase in demand for advanced and quality medical products and rising complexity with respect to product designing and engineering are anticipated to boost market growth. Rapid innovations in healthcare have increased the need for companies to incorporate new technologies and software applications in their products to meet the demand for validation and verification. Increase in product complexity, availability of newer types of material, and high risk of product failures are some of the key factors increasing the need for validation and verification services.

Browse full research report :
https://www.radiantinsights.com/research/medical-device-validation-&-verification-market

North America dominated the global medical device validation and verification market, accounting for 44.88% share of the overall revenue in 2019. Rapid growth in manufacturing of medical devices to meet high demand for efficient healthcare services, including validation and verification, is one of the major factors contributing to the regional market growth. In addition, stringent regulatory environment in U.S. is fueling market growth in the region.

Asia Pacific is anticipated to expand at a CAGR of 12.1% during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, improved regulatory framework, and increase in the number of medical devices companies.

Further key findings from the study suggest:
• Based on therapeutic area, oncology held the largest market share in 2019 and is expected to witness lucrative growth during the forecast period due to increasing prevalence of cancer worldwide

• On the basis of application, the diagnostic segment held the largest share of 44.16% in 2019 due to increasing demand for diagnostic technology in healthcare to identify the cause of disease

• The therapeutic application segment is projected to register the fastest growth during the forecast period due to rising prevalence of chronic diseases

• North America dominated the medical device validation and verification market and accounted for a share of 44.88% in 2019. This is attributed to rapid growth in manufacturing of medical devices to meet high demand for efficient healthcare services, including validation and verification

• Asia Pacific is anticipated to expand at a CAGR of 12.1% during the forecast period. This can be attributed to increased opportunities for players, especially in Japan, China, and India, and improved regulatory framework.

To get request a free sample :
https://www.radiantinsights.com/research/medical-device-validation-&-verification-market/request-sample

Global ambulance services market size is expected to reach USD 50.0 billion by 2027

March 20, 2020 - The global ambulance services market size is expected to reach USD 50.0 billion by 2027, expanding at a CAGR of 9.3%. Favorable reimbursement policies and rising medical tourisms are anticipated to fuel the demand for ambulance services over the forecast period.

The market is anticipated to grow due to favorable reimbursement policies in developed nations. In U.S., Medicare covers both non-emergency and emergency facilities for medically necessary cases, if the supplier fulfills stipulated requirements. In some circumstances, Medicare also covers unscheduled and irregular nonemergency trips. Medicare covers 80% of the approved amount for ambulance facility and the remaining 20% is covered by supplemental insurance policy of the patient. In New Jersey, Pennsylvania, and South Carolina, for repetitive, nonemergency trips, patients need prior authorization from Medicare Administrative Contractor (MAC). However, Medicare does not pay for ambulettes (wheelchair-accessible vans that provide nonemergency transportation).

In Victoria, Australia, patients can avail emergency medical assistance by securing a membership with Ambulance Victoria, which offers medical facilities at subsidized prices. Ambulance Tasmania provides free emergency medical assistance to Tasmanian residents. Residents of Queensland (Australia) are covered with the cost of emergency services across Australia, by the QLD state government. Similarly, in U.K., public healthcare system provides free emergency and non-emergency medical facilities. In addition, patients receive NHS funding for their treatment. In Germany, public health insurance (Gesetzliche Krankenversicherung) is compulsory for every citizen and this insurance also covers non-emergency and emergency medical facilities. Private health insurance (Private Krankenversicherung) is usually opted by those who have high yearly income.Ease of payment through reimbursement policies encourages patients to opt for emergency medical assistance more frequently, which is likely to bolster growth of the ambulance services industry.

Further key findings from the study suggest:

• The ground ambulance services segment held the largest market share in 2019 owing to the rising incidence of road accidents across the globe

• Emergency services segment is anticipated to witness the fastest growth over the forecast period owing to the increasing prevalence of cardiovascular diseases such as cardiac arrest, stroke, and congestive heart failure

• The ALS segment is expected to witness rapid growth owing to rising awareness about life support facilities and increase in technologically advanced equipment and trained personnel

• The key players in the ambulance services market include London Ambulance Service NHS Trust; Acadian Ambulance Service; BVG India Limited; Falck A/S; Air Medical Group Holdings Inc.; Air Methods Corporation; and Ziqitza Healthcare Limited.

Browse the Full Global Ambulance Services Market :
https://www.radiantinsights.com/research/ambulance-services-market

Download Free Request Sample :
https://www.radiantinsights.com/research/ambulance-services-market/request-sample

Diagnostic audiometer analyzes intensity and the tone of sounds, balance issues and other issues related to the function of inner ear

June 25, 2019 - According to a report available on Radiant Insights, Inc.; the global diagnostic audiometer market is projected to display steady growth by 2023. High prevalence of hearing disorders, growing health awareness, and technological developments in these devices can drive the market during the forecast period (2018 to 2023). In addition, growth in health care programs due to new regulatory framework is also expected to increase the sales of these devices. As, government as well as private organizations need screening audiometers for their screening programs. 

Rising incidence of hearing disability can be one of the key factors that can influence the market growth in the coming years. Hearing impairment is one of the largest health problems noticed in the recent years. This health condition cause due to several factors including aging, genetic factors, bacterial infections, are among the others. Growing occurrence of hearing disparity particularly among children is also expected to boost the demand for these devices. Also, increasing Alzheimer’s disease among older population can also resulted into hearing loss. This is also expected to supplement the market growth.

For better understanding read more @ 
https://www.radiantinsights.com/research/global-diagnostic-audiometer-market-outlook-2018-2023

Technological progressions can bode well for the market growth. Several modern-devices can be used separately or connected to a computer. Digital and portable audiometers are quite popular among the users. However, increasing use of advanced devices such as hybrid and PC-based audiometers are also expected to boost the market growth during the forecast period.

However, high associated with these devices along with reimbursement issues may hamper the market growth. On other hand, development of advanced products can support the market growth.

Worldwide diagnostic audiometer market can be segmented on the basis of type, application, and region. Geographically, the market can be divided into North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America is expected to show high growth during the forecast period. This growth can be ascribed to growth of patients with hearing loss and acceptance of technologically advanced audiometers for testing and screening of hearing loss. Additionally, growth of geriatric population in this region is also expected to be the crucial factor for the regional growth.  Asia Pacific is likely to display notable growth during the estimated period. This growth can be attributed to growing healthcare expenditures, improving healthcare infrastructure, and growth in age-related hearing problems. Increasing awareness about availability of technologically advanced audiology devices in this region can boost the regional growth.  Increasing population in developing countries such as China and India are also expected to create opportunities in the coming years. Europe is also considered as one of the crucial markets due to high prevalence of deafness in the region. In addition, presence of advanced healthcare infrastructure and high patient disposable income can have positive impact on the market.

To get free request sample :
https://www.radiantinsights.com/research/global-diagnostic-audiometer-market-outlook-2018-2023/request-sample

Key players operating in the diagnostic audiometer market include Natus Medical incorporated, William Demant Holding, AuditData A/S., Benson Medical instruments, and Micro-DSP Technology Co Ltd. The market looks competitive due to presence of several regional as well as international players. Many players in the market are involved in the development of PC-based audiometers.  For instance, Clearwater Clinical Limited, producer of iPad-based audiometers has recently released version 5.0 of its product, SHOEBOX Audiometry. The new version features patent-pending Response and Environment Adaptive Control Technology (REACT), which is intended to monitor patient response behavior and environmental conditions such as ambient noise levels.

Global infant radiant warmer market is projected to grow steadily by 2022

May 02, 2019 - According to a report available on Radiant Insights, Inc.; the global infant radiant warmer market is projected to grow steadily by 2022. Rising cases of premature births and growing awareness about the equipment can drive the market during the forecast period (2017 to 2022). Additionally, growing incidence of hospital acquired infections around the globe is also driving the demand for the equipment.

Read full research report :
https://www.radiantinsights.com/research/global-infant-radiant-warmer-market-outlook-2017-2022

Increasing acceptance of technologically advanced infant radiant warmers in hospitals across the world is expected to support the market growth in the coming years. The equipment provides protection to new born baby from cold temperature and infection. It is also used to maintain fluid balance and provide oxygenation. Several conditions such as neonatal sepsis, jaundice, neonatal sepsis anemia, and respiratory distress syndrome are generally diagnosed in neonatal intensive care unit.

The equipment is used to keep the new-born infants warm, who have severe heat loss in the early days of birth. Growing rate of hypothermia in infants is also considered as one of the crucial factors driving the market growth. For instance, as per the World Health Organization (WHO), in developing countries, more than 96% of babies born with weight less than 2,500g. therefore hypothermia is the most common condition among newborns. The thermoregulation devices are used to treat sick infants from hypothermia.

Furthermore, increasing government initiatives is also expected to support the market growth. For instance, the American Academy of Pediatrics (AAP) has added a level (level IV) in neonatal nursing. This anticipated to increase the adoption of infant radiant warmers. Also, growing number of hospitals across the world is also expected to augment the demand for this equipment. Since, adoption of neonatal intensive care unit (NICU) is mandatory as per government rules in many regions.

Worldwide infant radiant warmer market can be segmented on the basis of applications and region. Based on application, the market can be bifurcated into hospitals and birthing centers.

Geographically, the infant radiant warmer market can be divided into North America, Europe, Asia Pacific, Middle East and Africa, and South America. North America holds the major market share due to availability of advanced healthcare infrastructure healthcare infrastructure, growing expenditure for healthcare, and high disposable income. Presence of major companies is also responsible for the regional growth. However, Asia Pacific infant radiant warmer market is expected to show significant growth during the forecast period. This growth can be ascribed to rapid development in healthcare infrastructure and growing incidences of premature births in the region. Growing expenditure for healthcare in emerging countries such as India and China are expected to support the market growth in this region over the forecast period.

Prominent companies operating in the infant radiant warmer market include Medicor Elektronika, AVI Healthcare, Ertunc ozcan, TSE Medical, and GE Healthcare. Increasing number of companies into the manufacturing of neonatal warming equipment is expected to drive the market growth in the coming years. Increasing efforts from the companies to develop technologically advanced equipment is also expected to boost the market growth. For instance, Apollo Cradle, Women & Childrens’ Hospital based in India has recently introduced its ‘Advanced Technology Neonatal Intensive Care Unit’ (eNICU). With this advancement, the healthcare specialists will be able to monitor, medication levels, feeding pattern, nutrition, and growth charts of babies within hospitals or remotely. This eNICU will also help to support NICU’s in smaller towns. The real-time monitoring of pre-term babies, with complete digital records will help to improve clinical outcomes.

Request free sample :
https://www.radiantinsights.com/research/global-infant-radiant-warmer-market-outlook-2017-2022/request-sample

Growing need for technologically advanced medical equipment offering minimally invasive surgeries can drive demand for electrosurgical devices

April 09, 2019 - The global electrosurgical devices market is estimated to grow at steady CAGR over the forecast period (2013 to 2025), according to a report available on Radiant Insights, Inc. Growing need for technologically advanced medical equipment offering minimally invasive surgeries can drive demand for electrosurgical devices.

Shifting consumer preference for electrosurgery over traditional surgical methods can augment growth of market. Rising cases of chronic disorders like cancer, diabetes, and obesity owing to increasing geriatric population can augment market expansion. Supportive government initiatives to promote use of electrosurgical instruments can stimulate market growth. Growing awareness regarding availability of safe and innovative surgical techniques effective in cutting, devitalization, coagulation, and thermofusion.

In-Depth research report on Electrosurgical Devices Market :
https://www.radiantinsights.com/research/global-electrosurgical-devices-market-insights-forecast-to-2025

To cater to rising demand for advanced electrosurgical devices, most companies are likely to invest in R&D activities to develop new and innovative products. For instance, Olympus recently launched its new electrosurgical device named ESG-300 electrosurgery generator. The device can offer all kinds of modes and settings that are required by physicians while performing surgeries. In addition, it can offer novel technologies like SmartArgon mode that can automatically detect distance to tissue and can save surgical procedures. The design is expected to be user-friendly allowing physicians to select among various display languages.

The electrosurgical devices market can be segregated on the basis of product, end-user, and region. Based on product, the market can be categorized into electrosurgical instruments & accessories, electrosurgery instruments, and electrosurgery accessories. Electrosurgical instruments and accessories segment is anticipated to grow at significant CAGR over the forecast period.

Based on end-user, the electrosurgical devices market can be classified into general surgery, gynecology surgery, urologic surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, and neurosurgery. Orthopedic surgery segment is predicted to grow at substantial CAGR during the forecast period.

Regional segmentation of the electrosurgical devices market includes Asia Pacific, Europe, North America, Central & South America, and Middle East & Africa. North America dominated the market in the past attributed to existence of numerous key market players in the region. Growing adoption of innovative technology and availability of skilled labor can propel regional growth. In addition, rising cases of chronic disorders owing to geriatric population can also boost market expansion in the forthcoming years. Moreover, increasing healthcare expenditures and rising adoption of surgical procedures are anticipated to drive market growth over the forecast period.

In Asia Pacific, the electrosurgical devices market is predicted to witness highest CAGR over the forecast period owing to increasing use of minimally invasive surgical techniques. In addition, increasing foreign direct investment (FDI) coupled with presence of developing economies can drive regional growth. Moreover, rising cases of chronic disorders like cancer can influence market expansion in the forthcoming years.

To get a free sample request at:
https://www.radiantinsights.com/research/global-electrosurgical-devices-market-insights-forecast-to-2025/request-sample
 

European electrosurgical devices market is predicted to grow at steady CAGR during the forecast period attributed to increasing number of surgical procedures. Growing adoption of cosmetic and aesthetic surgeries among consumers can stimulate regional growth.  

Some of the leading companies operating in the electrosurgical devices market are Medtronic, Johnson & Johnson, Bovie Medical, KLS Martin, and Olympus Corporation. The market is anticipated to be less competitive attributed to less number of market players. However, rising demand for new and innovative medical devices can create lucrative opportunities for new entrants. Advent of local players in developing economies like India and China can drive competition level in the market. Easy availability of raw materials and cheap labor in these countries can boost market growth over the forecast period.

Infant incubator market is anticipated to expand at substantial CAGR of 9.2% by 2022

January 16, 2019 - The global infant incubator market is anticipated to expand at substantial CAGR of 9.2% by 2022, suggests a report added to the repository of Radiant Insights, Inc. Growing incidence of preterm births is anticipated to propel global market over the forecast period (2017 to 2022). This biomedical device offers intensive medical attention to newborn babies by providing warmth, humidity, and oxygen in a controlled environment. It can improve infant survival rate by retaining thermal stability within incubator and providing infection-free environment to infants. In addition, this device can protect infants from outside dust, noise, and infections. All these factors are expected to play a vital role in driving demand in the years to come.

Read full research report :
https://www.radiantinsights.com/research/global-infant-incubator-market-outlook-2017-2022

Rising number of Neonatal Intensive Care Unit (NICU) admissions is expected to positively influence growth of the market for infant incubators. Continual technological advancements to provide advanced medical care to premature infants can augment demand. Increasing birth rate of premature infants with lower birth weights and other problems can surge demand over the next few years. Favorable initiatives from governments and private organizations to improve healthcare facilities and to spread awareness regarding benefits of NICUs can further fuel market growth during the forecast period.

To cater to rising demand for infant incubators, companies focus on R&D activities to develop advanced products. For instance, NeoLight recently received clearance for its new product Skylife from the United States Food and Drug Administration (FDA). The device can deliver narrow band of high-intensity blue light via blue Light Emitting Diodes (LEDs) to provide treatment for neonatal unconjugated hyperbilirubinemia (jaundice). It is designed to be used within most neonatal enclosures including incubators, bassinets, and radiant warmers. This lightweight device features ergonomic and flexible design that allows clinicians to comfortably shift the unit between enclosures.

The worldwide infant incubator market can be segregated on the basis of application and region. Based on application, the market can be categorized into hospitals and birthing centers. The hospitals segment is expected to dominate the market over next few years. High adoption owing to complications during birth and premature birth rate is anticipated to propel demand over the forecast period.

Regional segmentation includes Europe, North America, Asia Pacific, South America, and Middle East and Africa. Asia Pacific is expected to witness significant growth in the forthcoming years attributed to rising adoption. In addition, growing incidences of premature babies in India, China, and other developing economies can impel regional market growth. Moreover, increasing investments to develop healthcare information technology solutions by leading market players can positively influence market for infant incubators.

North America is anticipated to lead global market on account of the presence of advanced medical care. It is expected to hold a high market share during the forecast period. Rising number of premature born babies and well-developed healthcare infrastructure can stimulate regional growth. United States (U.S.) is expected to hold the largest market share in North America over the forecast period.

Europe is anticipated to grow well over the forecast period attributed to rising number of premature child births. Germany is likely to hold the largest market share followed by France during the forecast period. Europe; being a developed region, can offer advanced healthcare infrastructure to its residents. This, in turn, is anticipated to bode well for regional market during the forecast period.

Some of the leading companies in the global infant incubator market are GE Healthcare, TSE Medical, AVI Healthcare Private Limited, Atom Medical Corporation, and Drager.

Download free request sample :
https://www.radiantinsights.com/research/global-infant-incubator-market-outlook-2017-2022/request-sample

Latest Anesthetic Gas Machines to Improve Surgical Outcomes

Anesthetic gas machines are devices used in delivering anesthesia to patients during surgery to alleviate pain. It is also known as Boyle’s machine or anesthesia machine. The instances of anesthesia awareness in patients have led to technological breakthroughs to accurately measure oxygen levels while delivering anesthesia.

Browse full research report :

https://www.radiantinsights.com/research/global-anesthetic-gas-machine-industry-2017

According to a study by researchers at Rutgers New Jersey Medical School in 2017, longer duration of anesthesia was directly proportional to surgical complications. The results of the study will be critical in taking preoperative steps to avoid surgical mishaps and minimize the possibility of mortality. The transition to sevoflurane from desflurane to reduce carbon emissions.

Reliance on Data Analytics

Major market applications of anesthetic gas machines are animals and humans. The animals segment is anticipated to showcase significant growth from 2012 to 2022 owing to rising expendable income of pet owners and emergence of pet insurance policies. Rise in animal research and a visible surge in veterinarians are also expected to influence the demand in the segment. The Fabius MRI machine by Dräger has been designed to provide sufficient oxygen to animals and compatible with MRI scans as well. In addition, the development of portable machines can lower the cost of pet surgeries as well.

The humans segment is purportedly expected to scale owing to rise in number of accidents and surgeries. The use of these machines in rural areas or developing countries to assist patients during emergencies has had a major impact. For instance, the Universal Anesthesia Machine (UAM) by Gradian Health Systems has been received with major enthusiasm by patients in Sierra Leone. The machine operates even during power outage and provides enough oxygen to complete the surgery.

Market Overview

The global anesthetic gas machine market is expected to expand from 2012 to 2022 (forecast period) owing to rise in number of surgeries. Technological advances in anesthetic machines and rising geriatric populace are factors projected to expedite market demand over the forecast period.

Rise in the number of pet surgeries is also expected to be a deciding factor influencing market growth. The preferable option of minimally invasive surgeries is predicted to create more market demand in the forthcoming years. Key market players include Philips Healthcare; Spacelabs Medical, Inc.; Mindray Medical International Limited; and Dräger.

Free request sample :

https://www.radiantinsights.com/research/global-anesthetic-gas-machine-industry-2017/request-sample

Early Diagnosis of Diseases to Spur High DTC Genetic Testing Kit Sales

Direct-to-consumer (DTC) genetic testing kits are services purchased by consumers through print advertisements, television, and the Internet. These kits possess the ability to detect and identify mutated strains of DNA that could evolve into chronic diseases. It could provide consumers with a forewarning to the possibility of attaining hereditary diseases due to the family medical history and genetic structure. Types of testing kits are individual health planning, medical precision tests, genome data bank, restrictive traits, and comprehensive genome test models.

Browse full research report :

https://www.radiantinsights.com/research/global-remote-patient-monitoring-devices-market-professional-survey-report-2017

Easy Detection of Rare Diseases

The end users that can sell DTC genetic testing kits are Internet, doctor’s office, and others. The Internet segment is expected to gain a large market share till 2022 due to easy access to Internet via smartphones and laptops. In addition, the relaxation of certain policies by regulatory agencies such as the U.S. Food and Drug Administration (FDA) has provided relief to companies such as 23andMe and Pathway Genomics. The Breast Cancer (BRCA) test by Color Genomics can detect the presence of BRCA1 and BRCA2 genes, the main cause of breast cancer in women and save lives.

The doctor’s office segment is predicted to gain a fair market share by 2022 due to test kit manufacturers allying with physicians or geneticists to sell their kits. In addition, these specialists can offer a comprehensive understanding of genetic test results. Patients can benefit from this advice and take appropriate steps to reduce the probability of gaining hereditary diseases.

Market Outlook

The global direct-to-consumer (DTC) genetic testing market is projected to experience a steady growth rate over the forecast period (2016-2022), according to a report on Radiant Insights, Inc. The demand for genetic tests to identify chronic diseases at an early stage is expected to be the key driving factor of the market.

The increasing healthcare costs, emphasis on personalized disease management, and consumer awareness of these tests due to Internet and television are factors predicted to spur market growth over the forecast period. Development of non-invasive tests to detect hereditary diseases is expected to open up new avenues for growth. Key market players include Navigenics, Inc.; Genetrainer; deCODE genetics Inc.; and 23andMe.

Free request sample :

https://www.radiantinsights.com/research/global-remote-patient-monitoring-devices-market-professional-survey-report-2017/request-sample

Spirometer - Spirometry is an effective method to diagnose and monitor respiratory health

The global spirometer market size is expected to reach around USD 1.3 billion by 2025, expanding at a CAGR of 9.4% over the forecast period. Chronic respiratory diseases are rising among adults and children worldwide. Over 2 billion people are currently estimated to be exposed to air pollution on a regular basis, driving the incidence rate of respiratory disorders. Diagnosis and monitoring of respiratory diseases has become crucial in hospitals as well as home settings.

Read full research report : https://www.radiantinsights.com/research/spirometer-market

Around 230 million people are affected by asthma across the globe. In addition, around 30% of pediatric hospitalizations are attributed to asthma. Asthma and related respiratory disorders have been increasing due to worsening environmental conditions. Spirometry is an effective method to diagnose and monitor respiratory health. The American Thoracic Society and the European Respiratory Society have been proactively working on the standardization of spirometry measurements and global guidelines.

The developed countries such as U.S. have reimbursement policies dedicated for spirometry through Medicare, Medicaid, and third-party insurance. The national spirometry amounts were increased due to revised Medicare Fee Schedule, 2018.

Further key findings from the report suggest:

• Steadfast increase in prevalence of Chronic Obtrusive Pulmonary Diseases (COPD) and adoption of technologically advanced diagnostic devices are some of the key drivers accountable for the growth of spirometers market across the globe

• In 2017, table top spirometers dominated the type segment in terms of revenue as they are widely used in hospitals, clinics, and other diagnostic centers

• Desktop spirometers are likely to witness the fastest growth in the coming years as the computer-based spirometry has become more popular among physicians as it reduces paperwork and offers automatic result interpretation

• Flow measurement spirometers dominated the technology segment in terms of revenue share in the year 2017. Peak flow measurement spirometers are anticipated to grow at the fastest rate over the forecast period

• Among applications, COPD held majority of the market share in 2017 pertaining to steep rise in cases of COPD across the globe. Whereas, asthma is expected to grow at the fastest rate in the years to come

• In the end use segment, hospitals and clinics held the largest market share in 2017 due to extensive use of spirometry in primary care settings. However, home healthcare is likely to experience impressive growth rate in the coming years

• North America dominated the market in terms of revenue share in 2017 as it has a large patient base with respiratory disorders. On the other hand, Asia Pacific is projected to showcase the fastest growth rate due to emerging economies such as China and India

• The market is witnessing developments of technologically advanced devices. In February 2015, Cohero Health, a U.S.-based company, received approval by the FDA for its hand held spirometer. This mobile spirometer is based on wireless technology and can be paired with computers, smart phones, and tablets for real-time monitoring and reporting

• Some of the key players in the spirometer market are Smiths Medical, Schiller AG, Nihon Kohden Corporation, and others.

Request a free sample :

https://www.radiantinsights.com/research/spirometer-market/request-sample

Muscle stimulator market size is progressing at a CAGR of 4.2% by 2025

The global muscle stimulator market size is expected to reach USD 853.09 million by 2025, progressing at a CAGR of 4.2% during the forecast period. Increasing number of patients suffering from chronic pain and rising healthcare spending in emerging countries are among the key trends stimulating the growth of the market.

 

In-Depth research report on Muscle Stimulator Market :  www.bit.ly/2zLp49f

Physiotherapists are increasingly shifting their preference from manual techniques to muscle stimulation devices, such as transcutaneous electrical nerve stimulation (TENS), and galvanic electrical stimulation to treat patients in clinical or home care settings. These muscle stimulation devices generate therapeutic currents that are useful for rehabilitation of muscles after an injury.

Anterior cruciate ligament (ACL) tear, hip flexor strains, and hamstring strains are some of the most common sports injuries that require muscle stimulation therapy. With increasing incidence of these muscle injuries among sportspersons, demand for muscle stimulators is projected to increase, thereby escalating the growth of the market.

Moreover, in several developed countries, musculoskeletal disorders is one of the key causes of physical disability. As per the statistics provided by the Arthritis Research U.K., about 35.2% of people in the U.K. were affected by musculoskeletal disorders in 2017. Such factors are estimated to bolster the growth of the market.

Further key findings from the report suggest:

• Transcutaneous electrical nerve stimulation is poised to exhibit a CAGR of 3.8% from 2017 to 2025

• Portable muscle stimulation devices dominated the market with a market share of over 35.0% in 2016 and are anticipated to witness a CAGR of 4.6% during the forecast period

• Pain management dominated the market with a valuation of USD 316.13 million in 2016 and is likely to expand at a CAGR of 4.4% during the forecast period

• Physiotherapy clinics dominated the market in 2016 and are expected to witness the highest CAGR of 4.9% during the same period

• Asia Pacific is estimated to witness a CAGR of 5.4% over the forecast period, owing to soaring need for better diagnostic devices and mounting cases of sports injuries

• Some of the prominent companies operating in the market are DJO Global, Inc.; Zynex, Inc.; NeuroMetrix, Inc.; RS Medical, Inc.; OMRON Corporation; Zimmer MedizinSysteme GmbH; BioMedical Life Systems, Inc.; EMS Physio Ltd.; Beurer GmbH; and OG Wellness Technologies Co., Ltd.

To get free request sample : www.bit.ly/2LncJsZ

Obesity is believed to be one of the foremost factors leading to diabetes in individuals

The global diabetes devices market size is expected to reach USD 35.5 billion by 2024. The market is projected to expand at a CAGR of 7.0% during the forecast period. Growing cases of diabetes, due to obesity, sedentary and unhealthy lifestyles, and several other factors, is expected to drive demand for diabetes devices over the next few years.

Obesity is believed to be one of the foremost factors leading to diabetes in individuals. According to WHO, in 2014, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese.

Some of the key companies in the global diabetes devices market are Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton, Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG, and Johnson & Johnson.

Further key findings from the study suggest:

• Constantly rising target population base is the primary factor driving market growth.

• Test strips capturedthe largest share in the monitoring and diagnostics device segment while insulin pens accounted for the largest revenue share among insulin delivery devices in 2016. This can be attributed to rapid adoption of these user-friendly, quick, and accurate devices for homecare use.

• North America is leading the regional market, followed by Europe. Advanced healthcare infrastructure and availability of technologically advanced products have driven the regional market.
  

• Key players in the market include Medtronic PLC, Sanofi S.A., Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.

Free request sample : www.bit.ly/2JvCKVl

To get more details : www.bit.ly/2NVD0Av

Bathroom and toilet assist devices : Aging demographics has created a demand for old-age homes and long-term care centers

The global bathroom and toilet assist devices market size is expected to reach USD 6.0 billion by 2025 at a 6.2% CAGR. Growth in prevalence of chronic diseases, coupled with aging population, has resulted in a rise in individuals with various disabilities. This has significantly driven the global market.

Browse full research report :

https://www.radiantinsights.com/research/bathroom-and-toilet-assist-devices-market

Aging demographics has created a demand for old-age homes and long-term care centers, both of which drive demand for bathroom and toilet assist devices. In addition, rising disposable income and government support toward home healthcare is supporting market growth.

On the other hand, longer product life cycle is primarily challenging the growth of the market. In addition, reusability of these devices is restraining revenue generation. However, growth in demand for these devices is predicted to lower the effect of the above-mentioned factors.

Further key findings from the report suggest:

• Commodes emerged as the largest product segment as a result of the many benefits offered such as improved adjustability, enhanced ease, and flap on seats

• Bath lifts and aids form the fastest growing segment owing to increase in number of patients with spinal injuries, which has spurred demand for various forms of mobility assist devices

• North America dominated the market in terms of revenue in 2016. Improved awareness regarding commercially available assist devices and increasing disposable income are propelling revenue generation in the region

• Europe is projected to witness swift growth during the forecast period owing to speedy adoption of advanced bathroom and toilet assist devices for patients with disabilities, to facilitate and reduce mobility issues

• Key players include ArjoHuntleigh; Medical Device Depot; Carex Health Brands; Juvo Solutions; Bischoff & Bischoff GmbH; Invacare Corporation; Prism Medical; Sunrise Medical LLC; and GF Health Products, Inc.

To get free request sample @

https://www.radiantinsights.com/research/bathroom-and-toilet-assist-devices-market/request-sample